Last updated: September 19, 2023
Sponsor: Cairo University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Pregnancy Complications
Treatment
methyldopa tablets 250mg + foot reflexology
methyldopa tablets 250mg
Clinical Study ID
NCT05888896
p.t.REC/012/003568
Ages 20-36 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Their ages were ranged between 20-36 years old.
- Their body mass index was not exceeding 35 kg/m2.
- All women were diagnosed as mild preeclampsia.
- All women were primipara and multipara.
Exclusion
Exclusion Criteria:
- Any fractures in foot.
- Foot ulcer & infection.
- Open skin wound in foot.
- History of stroke.
- Women less than 20 years and more than 36 years.
- BMI more than 35 Kg\m2.
- Severe preeclampsia.
Study Design
Total Participants: 60
Treatment Group(s): 2
Primary Treatment: methyldopa tablets 250mg + foot reflexology
Phase:
Study Start date:
June 09, 2023
Estimated Completion Date:
September 20, 2023
Study Description
Connect with a study center
Abeer Ali Ahmed Mansour
Assiut, Assuit 71511
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.